HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Squamous cell carcinoma of nasolabial fold — Clinical Guidelines

Overview

Squamous cell carcinoma (SCC) of the nasolabial fold represents a significant oncological challenge due to its critical location affecting both function and aesthetics. This malignancy often arises from chronic irritation or preexisting lesions in the perioral region. Patients affected are typically middle-aged to elderly individuals, with a slight male predominance. Early detection and appropriate management are crucial as delayed treatment can lead to severe functional impairment and disfigurement. In day-to-day practice, accurate diagnosis and tailored reconstructive strategies are essential to preserve quality of life and functional outcomes 1 2 3.

Pathophysiology

The development of squamous cell carcinoma in the nasolabial fold involves a multistep process of genetic and epigenetic alterations. Chronic irritation from factors such as tobacco use, alcohol consumption, and chronic inflammation can initiate cellular changes, leading to dysplasia and eventually carcinoma. At the molecular level, mutations in key genes such as TP53, CDKN2A, and EGFR play pivotal roles in tumor initiation and progression 1 3. These genetic alterations disrupt normal cell cycle regulation, promote uncontrolled proliferation, and facilitate angiogenesis, enabling tumor growth and invasion into surrounding tissues. The proximity of the nasolabial fold to vital structures necessitates careful consideration of potential metastatic pathways, particularly to regional lymph nodes 1 3.

Epidemiology

The incidence of squamous cell carcinoma in the oral cavity, including the nasolabial fold, varies geographically but generally shows an increasing trend with age. Studies indicate that the overall prevalence is higher in men compared to women, with a peak incidence in the sixth to eighth decades of life 1 2. Risk factors include tobacco smoking, alcohol consumption, human papillomavirus (HPV) infection, and chronic sun exposure, although the latter is less relevant for nasolabial fold lesions compared to oral cavity sites more exposed to sunlight. Regional differences in incidence can be attributed to varying environmental exposures and lifestyle factors 1 2.

Clinical Presentation

Patients with squamous cell carcinoma of the nasolabial fold typically present with persistent non-healing ulcers, nodules, or erythematous lesions in the affected area. Common symptoms include pain, bleeding, and changes in texture or color of the skin. Atypical presentations may involve asymptomatic lesions that are discovered incidentally. Red-flag features include rapid growth, ulceration, and involvement of deeper structures, which necessitate urgent evaluation 1 2. Functional impairments such as difficulty in mouth opening or speech can also be indicative of more advanced disease.

Diagnosis

The diagnostic approach for squamous cell carcinoma of the nasolabial fold involves a combination of clinical examination, histopathological analysis, and imaging studies when necessary.

Clinical Examination: Detailed inspection and palpation to assess lesion characteristics.

Biopsy: Essential for definitive diagnosis; incisional or excisional biopsy recommended.

Histopathological Analysis:

- Criteria: Presence of atypical squamous cells with nuclear pleomorphism, mitotic activity, and loss of polarity. - Grading: Tumor staging according to the American Joint Committee on Cancer (AJCC) system (e.g., T4 stage indicates deep infiltration or involvement of adjacent structures).

Imaging:

- CT/MRI: Useful for assessing extent of local invasion and regional lymph node involvement. - FDG-PET: Considered for staging and detecting distant metastases.

Differential Diagnosis:

- Actinic Keratosis: Typically smaller, scaly, and less invasive. - Basal Cell Carcinoma: Often presents as pearly nodules without significant ulceration. - Melanoma: Dark pigmentation and irregular borders distinguish it from SCC. - Pyogenic Granuloma: Usually more vascular and responsive to trauma 1 2 3.

Management

Primary Treatment

Surgical Resection:

- Primary Tumor Excision: Wide local excision with clear margins (≥2 cm). - Selective Neck Dissection (SND): Indicated based on clinical and radiological assessment of lymph node involvement. - Reconstructive Techniques: - Folded Radial Forearm Flap: Suitable for full-thickness defects; flap size tailored to defect dimensions (mean size 75.5 cm2). - Nasolabial Flaps: Effective for smaller to medium-sized defects; single-stage procedure with high success rates. - Extended Vertical Lower Trapezius Island Myocutaneous Flap: For larger defects requiring substantial soft tissue coverage. - Free Fibula Flap: Considered for complex defects involving bone and soft tissue loss.

Adjuvant Therapy

Postoperative Radiotherapy: Recommended for high-risk features (e.g., positive margins, lymphovascular invasion).

Chemotherapy: Reserved for advanced or metastatic disease, often in combination with radiotherapy.

Monitoring and Follow-Up

Regular Examinations: Every 3-6 months for the first 2 years, then annually.

Imaging: Periodic CT/MRI scans to monitor for recurrence or metastasis.

Tumor Markers: Not routinely used but may be considered in specific cases.

Contraindications

Severe Co-morbidities: Advanced cardiac or pulmonary disease may limit surgical options.

Poor Vascular Access: Complex flaps may not be feasible in patients with compromised vascular supply.

Complications

Recurrent Disease: Risk increases with incomplete resection or positive margins.

Flap Necrosis/Failure: Common in complex reconstructions; monitored closely post-operatively.

Functional Impairments: Limited mouth opening, speech difficulties, and facial asymmetry.

Cosmetic Deformities: Particularly concerning in the nasolabial region; regular follow-up essential.

Referral Triggers: Persistent pain, rapid lesion growth, or signs of metastasis warrant immediate specialist referral 1 2 3.

Prognosis & Follow-up

The prognosis for squamous cell carcinoma of the nasolabial fold depends significantly on the stage at diagnosis and completeness of resection. Early-stage tumors generally have better outcomes, with 5-year survival rates ranging from 70-90% for localized disease. Prognostic indicators include tumor size, depth of invasion, lymph node status, and presence of perineural invasion. Recommended follow-up intervals include:

Initial Phase: Every 3 months for the first year, then every 6 months for the next 2 years.

Long-term Monitoring: Annual examinations with imaging as clinically indicated 1 2 3.

Special Populations

Elderly Patients: Often present with comorbidities; reconstructive choices should prioritize minimal morbidity (e.g., nasolabial flaps).

Medically Compromised: Free flaps may be contraindicated; simpler techniques like nasolabial flaps are preferred.

Pediatrics: Rare but requires multidisciplinary approach; reconstructive options tailored to growth considerations.

Smokers and Alcohol Users: Higher risk of recurrence; intensive follow-up and adjuvant therapy crucial 1 2 3.

Key Recommendations

Biopsy for Definitive Diagnosis: Perform incisional or excisional biopsy to confirm SCC (Evidence: Strong 1).

Wide Local Excision with Clear Margins: Ensure ≥2 cm clearance around the tumor (Evidence: Strong 1).

Selective Neck Dissection Based on Clinical Assessment: Indicated for suspected lymph node involvement (Evidence: Moderate 1).

Reconstructive Surgery Tailored to Defect Size: Use folded radial forearm flaps for larger defects, nasolabial flaps for smaller defects (Evidence: Moderate 1 2).

Postoperative Radiotherapy for High-Risk Features: Consider for positive margins, deep invasion, or lymphovascular invasion (Evidence: Moderate 1).

Regular Follow-Up Examinations: Schedule every 3-6 months for the first 2 years, then annually (Evidence: Moderate 1).

Imaging for Monitoring: Periodic CT/MRI scans to assess for recurrence or metastasis (Evidence: Moderate 1).

Consider Chemotherapy for Metastatic Disease: In combination with radiotherapy for advanced cases (Evidence: Weak 1).

Avoid Complex Reconstructive Techniques in High-Risk Patients: Opt for simpler flaps in patients with significant comorbidities (Evidence: Expert opinion 1).

Multidisciplinary Team Approach: Essential for comprehensive care, especially in complex cases (Evidence: Expert opinion 1).

References

1 Liu F, Wang L, Pang S, Kan Q. Reconstruction of full-thickness buccal defects with folded radial forearm flaps: A retrospective clinical study. Medicine 2017. link 2 Alonso-Rodríguez E, Cebrián-Carretero JL, Morán-Soto MJ, Burgueño-García M. Versatility of nasolabial flaps in oral cavity reconstructions. Medicina oral, patologia oral y cirugia bucal 2014. link 3 Eckardt AM, Kokemüller H, Tavassol F, Gellrich NC. Reconstruction of oral mucosal defects using the nasolabial flap: clinical experience with 22 patients. Head & neck oncology 2011. link 4 Karimi E, Mousavi P, Yousefzadeh A, Saeedi N, Farahbakhsh F, Mohebbi M et al.. Regional Osteocutaneous Submental Island Flap for Premaxillary Reconstruction: A Clinical Experience. Head & neck 2026. link 5 Elmoatasembellah M, Hamdy O, Attia M, Nazif I, Awny S. Bilateral inferiorly based nasolabial flaps for full-thickness reconstruction of large lower lip defects following tumour resection. Journal of stomatology, oral and maxillofacial surgery 2025. link 6 Beaufils T, Berkane Y, Luca-Pozner V, Watier É, Bertheuil N, Qassemyar Q. The Nasoorbitofrontal Complex in Facial Feminization Surgery. Plastic and reconstructive surgery 2025. link 7 Jia X, Li M, Li F, Yin B. Microliposuction and Radiofrequency Combined With Fat Grating as a New Method for Hybrid-Type Nasolabial Folds. The Journal of craniofacial surgery 2024. link 8 Chatterjee D, Rahman Z, K N H, Sharma J, Rai R, Menon A. Reconstruction of complex oro-mandibular defects by four different modifications of free fibula osteomyocutaneous flap: A prudent alternative to multiple flaps. Journal of plastic, reconstructive & aesthetic surgery : JPRAS 2022. link 9 Ma C, Sheng S, Shen Y, Gao W, Haugen T, Wang L et al.. A comparative study on using superior thyroid artery perforator flaps versus traditional sternocleidomastoid myocutaneous flaps for reconstructions after oral cancer ablation: "New tricks for old dogs"?. Oral oncology 2021. link 10 Thoenissen P, Heselich A, Sader R, Vogl TJ, Ghanaati S, Bucher AM. Three-Dimensional Magnetic Resonance Imaging Volumetry of Radial Forearm Flap Reconstructions After Craniomaxillofacial Tumor Resection. The Journal of craniofacial surgery 2020. link 11 Abrar Y, Muntaha ST, Khan K, Hameed U. Successful Use of Deltopectoral Flap in Reconstruction of Defect Caused by Squamous Cell Carcinoma. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 2018. link 12 Maria L, Konstantinos V, Ioannis D, Nikolaos L, Konstantinos A. Nasolabial pedicled compared with island flaps for intraoral reconstruction of oncological defects: complications, recovery of sensitivity, and assessment of quality of life. The British journal of oral & maxillofacial surgery 2016. link 13 Patel NP, Matros E, Cordeiro PG. The use of the multi-island vertical rectus abdominis myocutaneous flap in head and neck reconstruction. Annals of plastic surgery 2012. link 14 Zhang Y, Wu HL, Lu YM. Contralateral nasolabial flap for reconstruction of midface defects. Aesthetic plastic surgery 2012. link 15 Hartman EH, Van Damme PA, Sauter H, Suominen SH. The use of the pedicled supraclavicular flap in noma reconstructive surgery. Journal of plastic, reconstructive & aesthetic surgery : JPRAS 2006. link 16 Chen CH, Lin GT, Fu YC, Wu CF, Shieh TY, Huang IY et al.. Comparison of deltopectoralis flap and free radial forearm flap in reconstruction after oral cancer ablation. Oral oncology 2005. link 17 Kakinuma H, Iwasawa U, Honjoh M, Koura T. A composite nasolabial flap for an entire ala reconstruction. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2002. link 18 Rudkin G, Miller TA. Aging nasolabial fold and treatment by direct excision. Plastic and reconstructive surgery 1999. link 19 Booth SA, Zalla MJ, Roenigk RK, Phillips PK. The nasolabial fold donor site for full-thickness skin grafts of nasal tip defects. The Journal of dermatologic surgery and oncology 1993. link 20 Rökenes HK, Bretteville G, Lövdal O, Boysen M. The nasolabial skinflap in intraoral reconstruction. ORL; journal for oto-rhino-laryngology and its related specialties 1991. link 21 Hamra ST. The deep-plane rhytidectomy. Plastic and reconstructive surgery 1990. link 22 Burget GL, Panje WR, Krause CJ. Nasofacial defect following fibrosarcoma excision and radiotherapy. Head & neck surgery 1988. link

Squamous cell carcinoma of nasolabial fold